UCSF Chancellor Susan Desmond-Hellmann on Tuesday outlined a new vision for UCSF — to be the world's preeminent health sciences innovator — as part of a three-year plan.
October 04, 2011
September 19, 2011
Faculty are encouraged to apply for the T1 Translational Catalyst Award, which is designed to help drive promising, early-stage research through the lengthy and complex process of bringing products and procedures to patients.
July 18, 2011
With renewed funding by the National Institutes of Health, the Clinical and Translational Science Institute at UCSF is poised to further accelerate the translation into clinical therapies, export its successes to other institutions and create initiatives to bring better health to more people more quickly. Explore this web package.
April 15, 2011
San Francisco Mayor Edwin M. Lee toured San Francisco General Hospital, where UCSF physicians and allied health care professionals provide patient care services, including the City's only level one trauma center.
November 16, 2010
UCSF and Pfizer, Inc. have formed a new partnership to accelerate the translation of biomedical research into effective new medications and therapies for patients.
November 04, 2010
UCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
May 19, 2010
Researchers have identified how a normal response to infection, one that usually serves to limit the amount of inflammation, actually contributes to disease progression and viral persistence in HIV-infected patients.
May 07, 2010
A long-held vision came into view Monday as UCSF neuroscientists and clinical researchers shared their ambitious plans to attack debilitating neurological diseases through innovative collaborations.